Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1981 2
1982 1
1983 3
2005 1
2006 2
2007 1
2008 3
2009 2
2010 1
2011 3
2015 2
2019 4
2020 3
2021 1
2022 1
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
The Lancet Commission on medicine, Nazism, and the Holocaust: historical evidence, implications for today, teaching for tomorrow.
Czech H, Hildebrandt S, Reis SP, Chelouche T, Fox M, González-López E, Lepicard E, Ley A, Offer M, Ohry A, Rotzoll M, Sachse C, Siegel SJ, Šimůnek M, Teicher A, Uzarczyk K, von Villiez A, Wald HS, Wynia MK, Roelcke V. Czech H, et al. Among authors: offer m. Lancet. 2023 Nov 18;402(10415):1867-1940. doi: 10.1016/S0140-6736(23)01845-7. Epub 2023 Nov 8. Lancet. 2023. PMID: 37951225 Review. No abstract available.
Statement on the Lancet Commission on Medicine, Nazism, and the Holocaust.
Chelouche T, Czech H, Fox MA, Hildebrandt S, Lepicard E, Ley A, Offer M, Ohry A, Reis SP, Roelcke V, Rotzoll M, Sachse C, Siegel SJ, Šimůnek M, Teicher A, Uzarczyk K, von Villiez A, Wald HS, Wynia MK. Chelouche T, et al. Among authors: offer m. Lancet. 2023 Nov 18;402(10415):1816-1817. doi: 10.1016/S0140-6736(23)02461-3. Epub 2023 Nov 8. Lancet. 2023. PMID: 37951227 No abstract available.
Carfilzomib therapy for relapsed myeloma: results of a UK multicentre experience.
Djebbari F, Hubenov H, Neelakantan P, Wolf J, Offer M, Khera A, Louka E, Vallance G, Kothari J, Moore S, Ramasamy K. Djebbari F, et al. Among authors: offer m. Br J Haematol. 2020 Feb;188(4):e57-e60. doi: 10.1111/bjh.16324. Epub 2019 Dec 2. Br J Haematol. 2020. PMID: 31792927 Free article. Clinical Trial. No abstract available.
Ixazomib, lenalidomide, and dexamethasone is effective and well tolerated in multiply relapsed (≥2nd relapse) refractory myeloma: a multicenter real world UK experience.
Maouche N, Kishore B, Jenner MW, Boyd K, Bhatti Z, Bird SA, Chander G, Robinson R, Vallance GD, Offer M, Kothari J, Peniket A, Aitchison R, Dungarwalla M, Collings F, Bygrave C, Ramasamy K. Maouche N, et al. Among authors: offer m. Leuk Lymphoma. 2021 Jun;62(6):1396-1404. doi: 10.1080/10428194.2020.1864355. Epub 2020 Dec 25. Leuk Lymphoma. 2021. PMID: 33356703
31 results